福安药业(300194.SZ)：盐酸尼卡地平注射液收到药品注册证书

Core Viewpoint - Fuan Pharmaceutical has received a drug registration certificate from the National Medical Products Administration for its product, Nicardipine Hydrochloride Injection, which is indicated for the emergency management of severe hypertension during surgery [1] Company Summary - Fuan Pharmaceutical's wholly-owned subsidiary, Ningbo Tianheng Pharmaceutical Co., Ltd., is responsible for the newly approved Nicardipine Hydrochloride Injection [1] - The drug is specifically designed for the urgent treatment of abnormal high blood pressure, particularly in surgical settings [1]